(VIANEWS) – MAGNORA (MGN.OL), BASIC-FIT (BFIT.AS), SONAE (SON.LS) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. MAGNORA (MGN.OL)
210.1% sales growth and 52.28% return on equity
Magnora ASA operates as a renewable energy development company. It primarily focuses on developing wind and solar photovoltaic (PV) projects. The company also hold license agreements with the Dana Western Isles and Shell Penguins FPSO. It serves oil companies and marine contractors in the United Kingdom, Norway, and Sweden. The company was formerly known as Sevan Marine ASA and changed its name to Magnora ASA in October 2018. Magnora ASA was incorporated in 2001 and is based in Oslo, Norway.
Earnings Per Share
As for profitability, MAGNORA has a trailing twelve months EPS of kr3.95.
PE Ratio
MAGNORA has a trailing twelve months price to earnings ratio of 7.41. Meaning, the purchaser of the share is investing kr7.41 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 52.28%.
Yearly Top and Bottom Value
MAGNORA’s stock is valued at kr29.25 at 21:20 EST, way below its 52-week high of kr38.60 and way higher than its 52-week low of kr19.80.
Sales Growth
MAGNORA’s sales growth is negative 94.8% for the current quarter and 210.1% for the next.
Volume
Today’s last reported volume for MAGNORA is 93113 which is 23.24% below its average volume of 121305.
More news about MAGNORA.
2. BASIC-FIT (BFIT.AS)
31.3% sales growth and 4.68% return on equity
Basic-Fit N.V., together with its subsidiaries, engages in the operation of fitness clubs. It operates 1200 clubs under Basic-Fit brand in Netherlands, Belgium, Luxembourg, Germany, France, and Spain. The company was founded in 1984 and is headquartered in Hoofddorp, the Netherlands.
Earnings Per Share
As for profitability, BASIC-FIT has a trailing twelve months EPS of €0.27.
PE Ratio
BASIC-FIT has a trailing twelve months price to earnings ratio of 99.56. Meaning, the purchaser of the share is investing €99.56 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.68%.
Volume
Today’s last reported volume for BASIC-FIT is 13843 which is 88.34% below its average volume of 118791.
More news about BASIC-FIT.
3. SONAE (SON.LS)
10.5% sales growth and 9.35% return on equity
Sonae, SGPS, S.A. engages in retail, financial services, technology, shopping center, and telecommunications businesses. The company operates hypermarkets under the Continente brand; convenience supermarkets under the Continente Modelo and Continente Bom Dia brands; franchised supermarkets under the Meu Super brand; cafeteria under the Bagga brand; healthy food supermarkets and restaurants under the Go Natural brand; book shops and stationery under the Make Notes and Note! brands; health, well-being, and eye care centers under the Well´s brand; and dental and aesthetic medicine clinics under the Dr. Well's brand, as well as provides dog and cat products and services under the ZU brand. It also offers clothing, footwear, and accessories under the MO brand; baby and children clothing, footwear, and accessories, as well as childcare products under the Zippy and Losan brands; and jeans, clothing, and accessories under the Salsa brand. In addition, the company sells consumer electronics and entertainment products under the Worten brand; and mobile telecommunications products under the Worten Mobile brand, as well as develops real estate properties. Further, it offers payments, cards, personal loans, and insurance under the Universo brand; financing online purchases under the Universo Flex brand; and meal vouchers, gifting, and rewarding under the Da cards brand, as well as operates sports retail stores under JD, Sprinter, and Size? brand names. Additionally, the company provides telecommunication services to residential, personal, corporate, and wholesale markets; and investment management activities. It operates in Portugal, Spain, France, the United Kingdom, Germany, Italy, Romania, Brazil, Mexico, the Netherlands, and internationally. Sonae, SGPS, S.A. was founded in 1959 and is headquartered in Maia, Portugal. Sonae, SGPS, S.A. operates as a subsidiary of Efanor Investimentos SGPS, SA.
Earnings Per Share
As for profitability, SONAE has a trailing twelve months EPS of €0.11.
PE Ratio
SONAE has a trailing twelve months price to earnings ratio of 8.18. Meaning, the purchaser of the share is investing €8.18 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.35%.
Sales Growth
SONAE’s sales growth is 25.6% for the current quarter and 10.5% for the next.
Moving Average
SONAE’s worth is below its 50-day moving average of €0.95 and below its 200-day moving average of €0.97.
More news about SONAE.
4. VISTIN PHARMA (VISTN.OL)
6.6% sales growth and 16.03% return on equity
Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. The company was founded in 1969 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, VISTIN PHARMA has a trailing twelve months EPS of kr1.
PE Ratio
VISTIN PHARMA has a trailing twelve months price to earnings ratio of 24.3. Meaning, the purchaser of the share is investing kr24.3 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.03%.
Yearly Top and Bottom Value
VISTIN PHARMA’s stock is valued at kr24.30 at 21:20 EST, below its 52-week high of kr25.10 and way higher than its 52-week low of kr16.10.
Sales Growth
VISTIN PHARMA’s sales growth is 10.6% for the ongoing quarter and 6.6% for the next.
Volume
Today’s last reported volume for VISTIN PHARMA is 9501 which is 32.7% below its average volume of 14119.
More news about VISTIN PHARMA.
